About-cancer/treatment/drugs/recombinant-hpv-quadrivalent-vaccine

From loveco.care
Jump to navigation Jump to search
Other languages:
English

Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine

This page contains brief information about recombinant human papillomavirus (HPV) quadrivalent vaccine and a collection of links to more information about the use of this vaccine, research results, and ongoing clinical trials.

US Brand Name(s)

Gardasil

FDA Approved

Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Recombinant human papillomavirus (HPV) quadrivalent vaccine is approved to prevent some conditions caused by certain types of HPV. The vaccine protects against four different types of HPV.

It is used in individuals aged 9 to 26 years to prevent the following:

  • Anal cancer.
  • Cervical cancer.
  • Vaginal cancer.
  • Vulvar cancer.
  • Lesions that sometimes lead to anal, cervical, vaginal, or vulvar cancer.
  • Genital warts.

Recombinant HPV quadrivalent vaccine is no longer available in the United States. It is still used in other countries.

More About Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Human Papillomavirus (HPV) Vaccine - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections

The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool

Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents

HPV Vaccination Linked to Decreased Oral HPV Infections

HPV Infections Targeted by Vaccine Decrease in U.S.

HPV and Cancer

Vaccine Reduces HPV Infections in Young Men

Human Papillomavirus (HPV) Vaccines

Clinical Trials Accepting Patients

Find Clinical Trials for Recombinant Human Papillomavirus Quadrivalent Vaccine - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

Retrieved from "http://www.loveco.care/index.php?title=About-cancer/treatment/drugs/recombinant-hpv-quadrivalent-vaccine&oldid=3662"